Aurora Cannabis Q2 results: shares up 2% after earnings revenue beats estimates

The Canadian marijuana company has a better-than-expected Q2 earnings report.

Aurora Cannabis shares are slightly up after reporting its second quarter (Q2) earnings. Aurora Cannabis’ Q2 revenue report was better-than-expected.

Aurora Cannabis earnings: key figures

Gross revenue $62 million
Net revenue $54.2 million
Kilograms produced 7,822
Kilograms sold 6,899

Aurora Cannabis earnings

Aurora Cannabis’ Q2 earnings increased with gross revenue rising 430% higher than the last quarter to $62 million. The Canadian-based marijuana company also reported that revenue in the last three months of 2018 quadrupled.

While the gross revenue surged, the net revenue had a more modest increase. The lackluster net revenue is because of the taxes Canada imposes on recreational marijuana and the net loss to Aurora Cannabis’ profits. The company’s net loss was $237.8 million, losing $4 for every $1 corporation made. The loss was also likely because of the drop in the average price of dried marijuana. The chief executive officer, (CEO), Terry Booth, spoke about Aurora Cannabis’ revenue.

‘Aurora continues to execute strongly across all of its market segments, as demonstrated by the 83% revenue growth over last quarter and the significant increase in confirmed production results. Our brands continue to resonate extremely well in the consumer market, our patient numbers continue to increase steadily, and we have maintained our market leadership in Germany and other key international markets. We are experiencing exceptional demand for our Canadian medical and consumer products, as well as sustained strong demand internationally,’ said Booth.

What do Aurora Cannabis’ Q2 results mean for their share price?

Aurora Cannabis’ Q2 results meant a slight decrease in shares before a rebound. Aurora Cannabis’ earnings mean that the positive report should cause an increase in its $9.75 share price.

How do Aurora Cannabis’ Q2 results compare to other marijuana stocks?

Aurora Cannabis’ Q2 results are much more profitable compared to Aphria. Aphria’s last reported revenue was just 21.7 million, but the stock rose 9% the day after releasing its earnings report.

What is in Aurora Cannabis’ future outlook?

Aurora Cannabis’ outlook includes exporting marijuana to the UK,Poland, and Mexico. The company also expects to increase production of cannabis from 120,000 kilograms to 150,000 kilograms at its Aurora Sky facility. The corporation also expects its operating costs to be under $1 per gram of marijuana. Aurora Cannabis also expects an increase in revenue because of an increase in high-quality production of its marijuana.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
Sell
Buy
Updated
Change
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sell
Buy
Updated
Change

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Sell
Buy
Updated
Change
-
-
-
-
-
-
-
-
-
-
-
-
China 300
-
-
-
-

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.